![]() |
|
|
Vol. 27, Issue 11, 1225-1231, November 1999
Department of Pharmacy, University of Tokyo Hospital,
Faculty of Medicine, University of Tokyo, Hongo, Bunkyo-ku, Tokyo,
Japan (Ka.Y., T.I.); Biopharmaceutical and Pharmacokinetic Research
Laboratories, Fujisawa Pharmaceutical Co., Ltd., Kashima, Yodogawa-ku,
Osaka, Japan (Ka.Y.); Department of Clinical Pharmacology School of
Medicine, Gunma University, Showa-machi, Maebashi, Japan (Ko.Y.);
Department of Pharmacy, The Research Hospital, The Institute of Medical
Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, Japan
(H.K.); Faculty of Pharmaceutical Sciences, Kyushu University,
Maidashi, Higashi-ku, Fukuoka, Japan (S.T., H.M., Y.S.)
To predict the degree of accumulation of hepatic metabolic
inhibitors in the liver from the in vitro data, we investigated the
relationship between cell/medium concentration ratios (C/M ratios) in
isolated rat hepatocytes and liver/blood unbound concentration (KBf) after i.v. administration of various metabolic
inhibitors such as itraconazole, ketoconazole, verapamil,
diltiazem, enoxacin, ciprofloxacin, clarithromycin, cimetidine, and
nizatidine. The C/M ratios of itraconazole were ~6000 and 200 at the
concentrations of 0.1 and 10 µg/ml, respectively, and the uptake of
ketoconazole and verapamil into the hepatocytes also showed a
concentration dependence, although the degree was smaller than that of
itraconazole. The uptake of diltiazem, enoxacin, ciprofloxacin, and
clarithromycin into the hepatocytes showed linear profiles on
concentration dependence. There was an excellent correlation between
C/M ratios and KBf values of all nine drugs with a slope of
1. This finding suggested the possibility of predicting drug
concentrations in the liver (CH) from C/M ratios, the blood
concentrations of drugs (CB) and unbound fraction in blood
(fB), which was expressed by CH = (C/M) · CB · fB. It may be possible to predict
the drug concentrations in human liver from KBf values
estimated with isolated human hepatocytes and concentrations in the
blood in a similar manner as in rats.
This article has been cited by other articles:
![]() |
K. A Bachmann and J. D Lewis Predicting Inhibitory Drug-Drug Interactions and Evaluating Drug Interaction Reports Using Inhibition Constants Ann. Pharmacother., June 1, 2005; 39(6): 1064 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Jones, D. Hallifax, and J. B. Houston QUANTITATIVE PREDICTION OF THE IN VIVO INHIBITION OF DIAZEPAM METABOLISM BY OMEPRAZOLE USING RAT LIVER MICROSOMES AND HEPATOCYTES Drug Metab. Dispos., May 1, 2004; 32(5): 572 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Greenblatt, L. L. von Moltke, J. S. Harmatz, S. M. Fogelman, G. Chen, J. A. Graf, P. Mertzanis, S. Byron, K. E. Culm, B. W. Granda, et al. Short-Term Exposure to Low-Dose Ritonavir Impairs Clearance and Enhances Adverse Effects of Trazodone J. Clin. Pharmacol., April 1, 2003; 43(4): 414 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kotegawa, B. E. Laurijssens, L. L. von Moltke, M. M. Cotreau, M. D. Perloff, K. Venkatakrishnan, J. S. Warrington, B. W. Granda, J. S. Harmatz, and D. J. Greenblatt In Vitro, Pharmacokinetic, and Pharmacodynamic Interactions of Ketoconazole and Midazolam in the Rat J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1228 - 1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Skov, K.M. Main, I.B. Sillesen, J. Muller, C. Koch, and S. Lanng Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide Eur. Respir. J., July 1, 2002; 20(1): 127 - 133. [Abstract] [Full Text] [PDF] |
||||